Leadership Team

We are in the midst of exciting times. Healthcare is a ubiquitous need and a business directed at serving humanity. However much remains to be done.

In spite of a recalibrated growth in India’s GDP of 5%, the demand supply gap for healthcare delivery services in the country remains considerable. The Indian healthcare market is expected to reach US$ 119.6 Bn by 2015, reflecting a CAGR of 15.0%. Currently, India accounts for nearly 6% of the world hospital beds and shares 20% of the world’s disease burden. This will grow, as India surpasses China by 2030 to become the most populous country in the world. The ageing profile of its citizens, higher purchasing power, growing affluence and a higher incidence of chronic life style and non-communicable diseases, will continue to fuel demand for healthcare services. (Source: Frost & Sullivan report, “Independent Report on the Healthcare Industry in the Asia Pacific regions, 17 September 2012”).

In order to address this enormous need for healthcare, Fortis has sharpened its focus on its India business, mainly hospitals. There are many reasons that favour this decision.

In India, we have the advantage of scale and size, and we enjoy a leadership position. We believe that an India focus works to our advantage as we can ramp up our businesses faster at far lesser incremental expense by leveraging our existing infrastructure in the country. To strengthen our model, we have also taken several strategic measures. This financial year our plan was to add 1,000 new hospital beds through greenfield hospitals. In May 2013, we launched the Fortis Memorial Research Institute, Gurgaon, and in January 2014 we launched Fortis Ludhiana. With the addition of the new, Fortis Arcot Road hospital in Chennai, due soon, we will be meeting our objective.

Fortis, with its large network of 62 healthcare facilities spread across India is a highly respected brand, well recognised for comprehensive services and quality. It enjoys a leadership position and is well known for its operational capability, deep experience and knowledge. The greatest strength of the company lies in its people –our pool of doctors, paramedics, nurses and managerial talent – and processes. This talent pool and knowledge of processes can be easily scaled up and replicated, giving us the unique ability to ensure quality patient care.

Continuous improvement in the way we work to deliver value to our patients is central to how we think and act. The organisation has invested considerable time in the improvement and standardisation of processes, ensuring a consistently high level of service across our hospitals. Other high impact organisation building programmes included the creation of shared services for the Group to drive both efficiencies and economies of scale in the supply-chain and important back office operations.

We thank our Doctors, Paramedics, Nursing, Administrative Staff and all other Fortisians who have put in dedicated efforts to make a difference to every patient. This sense of dedication and personal involvement has helped the organisation to continually improve upon its own benchmarks of patient satisfaction, service quality, clinical outcomes and efficiency. Our objective is to create a culture that delivers high quality healthcare with warmth and empathy, generating sustainable value for patients and all our stakeholders.

We started Fortis with the intent to serve the people of India and have been successful in our efforts to bring world-class capability, technology and local medical talent in alleviating the burden of disease. We are also happy to see that the Industry is maturing and that India is well poised to leverage its vast Indian medical talent, technology, infrastructure, systems and processes, to provide world-class medical treatment, with care and compassion, at price points that are affordable.

More and more international patients are beginning to seek medical attention here in India as it makes its mark on the world map as a value market for medical travel, on account of its high quality of medical care, superior service and affordability. We are confident that India will actualise its true potential as the preferred global healthcare destination in the foreseeable future.

As we move forward in our journey we would like to thank you for your unstinting support and look forward to your continued commitment to Fortis and to the future of healthcare.

With warm regards,

Malvinder Mohan Singh
Executive Chairman
&
Shivinder Mohan Singh
Executive Vice Chairman

Malvinder Mohan Singh

Executive Chairman, Fortis Healthcare Limited

Malvinder is a dynamic, young business leader who has made a mark on the global landscape by simultaneously pursuing the twin objectives of business for profit and for public good, in a way that positively impacts lives.

With the intent of providing broad based world class services through transformative business and delivery models, Malvinder is shaping the contours of the healthcare and financial services industries and driving their evolution.

In Healthcare, Malvinder incubated and established Fortis Healthcare Limited, in the late 1990's. Since then, he has been instrumental in transforming it into a leading healthcare delivery company in India and more recently in Asia, as the largest emerging healthcare organisation.

With a vision of making quality healthcare services accessible to all, he continues to assiduously pursue this objective, to make it a reality, using innovative business models.

In the Financial Services and Insurance sectors, Malvinder has business interests through Religare Enterprises. As Chairman of the company till 2010, he evolved Religare's strategy of creating an integrated financial services organization in India and an emerging global asset management platform.

Previously, Malvinder was Chairman, MD and CEO of Ranbaxy Laboratories. He led the expansion of Ranbaxy through a series of strategic partnerships and acquisitions resulting in Ranbaxy becoming a top 10 generic pharmaceutical company, globally. He spearheaded the coming together of Ranbaxy and Daiichi Sankyo, to create the world's fifteenth largest pharmaceutical company – a move seen as a game-changer by industry experts.

Malvinder strongly believes in the ability of people to do extraordinary things, in challenging environments. In a precedence setting move, he entrusted the management of Religare to a professional management team by stepping down as Chairman of the company in 2010. He continues to oversee his family's majority interest in Religare, as shareholder.

Malvinder has always supported strategic business decisions in the best interest of the companies he has led and continues to lead. The sale of his personal stake in Ranbaxy to Daiichi Sankyo, to secure longevity and a place for Ranbaxy as a top ranking Global Pharmaceutical Company and his decision to exit investments in Parkway Healthcare, emphatically demonstrated his ability to steer his companies, always keeping the best interests of its stakeholders, in mind.

Malvinder has a strong personal belief in the social responsibility of individuals and corporates. With a focus on affordability and accessibility to life saving medicines in emerging and under developed countries; he channelled resources towards innovation, to reduce the cost of ARV medication and for the development of a new low cost synthetic anti-malarial drug. He keenly supports initiatives to provide curative and preventive healthcare to the under privileged in India's villages and urban slums through various foundations and trusts.

Malvinder is a member of the Board of Visitors at the Fuqua School of Business (Duke University, USA) and the Board of the Indian Council for Research on International Economic Relations (ICRIER). He was a member of the first batch of the Young Global Leaders initiative of the World Economic Forum. A graduate in Economics, he earned his MBA from the Fuqua School of Business, Duke University, USA.

Shivinder Mohan Singh

Executive Vice Chairman, Fortis Healthcare Limited

Shivinder Mohan Singh is an entrepreneur who aspires to change the way Healthcare is delivered in the world. He is the Executive Vice Chairman of Fortis Healthcare Limited, a leading, integrated healthcare delivery provider in the Pan Asia-Pacific region. Fortis' healthcare verticals span primary healthcare, speciality day care, diagnostics and hospitals, with an asset base in 10 countries, many of which represent the fastest-growing healthcare delivery markets in the world. Fortis is driven by the vision of becoming a global leader in the integrated healthcare delivery space and the larger purpose of saving and enriching lives through clinical excellence.

Shivinder is also one of the principal promoters of Religare Enterprises Limited, Super Religare Laboratories Limited and Religare Technologies Limited. He was one of the key promoters of global pharma major Ranbaxy Laboratories and a director on its board; playing a strategic role in its sale and in taking the company to the next level, while creating significant long-term value for all stakeholders.

Shivinder has done his MBA with specialisation in health sector management from the Duke University Business School, USA. His significant contribution to Indian Healthcare is widely acknowledged. His strategy for Fortis, and its execution, has been recognised by the Harvard Business School as a case study. For over a decade, Shivinder has led from the front in shaping the private healthcare space in India. He is an alumnus of Doon School and an Honours Graduate in Mathematics from St. Stephens College, Delhi. He has lead various healthcare bodies and state level initiatives for the industry. He is also the Chairman of the Membership Committee of FICCI (Federation of Indian Chambers of Commerce and Industry).

While healthcare is a passion for Shivinder, his dream is to contribute in building a vibrant India. He is involved in a number of initiatives focused on social change - a better future for the girl child, HIV education, quality healthcare in Rural India and more. Shivinder is on the board of visitors of Fuqua School of Business, Duke University, USA and the board of trustees of Aspen India. He is also on the national board of advisors for AIESEC, a global, non-political and independent, not-for-profit organization run by students and graduates from institutions of higher education.

Shivinder lives with his wife Aditi and their four sons, in New Delhi. He likes sports such as football and tennis and enjoys watching films! .

Mr. Sunil Godhwani is the Chairman and Managing Director of Religare Enterprises Limited (REL). A man with a vision to create a global business of excellence, he is the inspiration to all as he spearheads REL's management and global operations; strategizing and directing it through its next phase of growth.

Mr. Godhwani brings with him strong leadership skills, vigor and a passion for excellence. He believes in nurturing a culture that is entrepreneurial, result oriented, customer focused and based on teamwork. He has given strategic direction to Religare's growth since his joining in 2001. He has been instrumental in establishing Religare's vast network and shaping the Company's strategies in India and abroad. He is on a constant lookout for taking it to new heights by managing various acquisitions, finding new partners for joint ventures and scouting new avenues for the business. Under his able leadership, Religare Enterprises Limited is India's fastest growing, integrated financial services company with a significant presence in 15 countries across Asia, Africa, Middle East, Europe and the Americas.

He also held the various key positions such as Member of the Economic Policy Council and the Task Force on Indian Financial Markets of the Confederation of Indian Industry (CII), Member of the Executive Committee of the Federation of Indian Chambers of Commerce & Industry (FICCI), Member of the Managing Committee of The Associated Chambers of Commerce and Industry of India (ASSOCHAM). He is also a director on the Boards of various Religare group companies.

He has a diverse and wide-ranging experience of over two decades in managing large scale businesses. A powerful orator and a great motivator, he has been awarded with many awards and accolades. In the year 2008, he was awarded with Outlook Money - NDTV Profit Awards 2008' for "Best New IPO Listing" presented by Mr. C.B Bhave, former Chairman-Securities & Exchange Board of India, in 2009, he was conferred the "CEO of the year" Award at the CEO CLUBS INTERNATIONAL AWARDS, Dubai and 'Udyog Rattan Award' and Religare Enterprises Limited with 'Excellence Award' by Institute of Economic Studies at Indian Habitat Centre, In 2010, he got, 'India Business Leader of the Year' at the Global Indian Business Meeting hosted by Horasis, in Madrid, Spain and also Best M&A Deal in the Health/Life Sciences Category" at the 8th Annual M&A Awards held in New York for the 'Acquisition of strategic stake in Parkway Holdings by Fortis Healthcare Ltd'. He is a prolific writer and speaker at important industry platforms and publications. He continues to play a key role as part of the Indian contingent at the World Economic Forum at Davos. He was speaker at 2010 Buttonwood Gathering held at New York alongside eminent personalities like Vikram Pandit, Stephen Roach and Wilbur L. Ross Jr. also featured in The Economic Times, India's largest business daily, as one of the key people to watch out for in the BFSI space

Born in New Delhi, he completed his schooling from prestigious St. Columba's School post which he went abroad for studying. He holds a B. Sc. Degree in Chemical Engineering and a M.Sc. in Industrial Engineering & Finance from Polytechnic Institute of New York.

Harpal Singh has wide ranging experience in the Corporate and Social sectors and has held leadership positions in the Automobile, Consumer Products and Healthcare sectors. He was Non Executive Chairman of India's largest Pharmaceutical Company, Ranbaxy and is currently the Mentor and Chairman Emeritus of Fortis Healthcare.

Whilst chairing the Impact Group, he sits on the Board of Fortis Healthcare Limited, Religare Enterprises Limited, Religare Technologies Limited, Fortis Clinical Research Limited and Super Religare Laboratories Limited. He is associated at the Board level with some of India's most renowned schools which include the Doon School, the Scindia School, the Yadavindra Public School and Salwan Schools where, he is Vice Chairman of the Trust. He is also a member of the National Round Table on School Education. He is a member of the Board of Governors of IIT, Indore as also of the NIIT University. He is a member of India-UK Round Table, India-US Strategic Dialogue and of the Public Health Foundation of India.

He is Founder Chairman Trustee of Nanhi Chhaan and Chronic Care Foundations. Nanhi Chhaan Foundation focuses around the girl child, women's empowerment, tree plantation and environment issues and secularism. Mr. Singh is Chair of INDIA800 Foundation, India Office. He is currently the Chairman of the Save the Children, India and is also a Director of the Global Board of Save the Children International.

Harpal Singh, graduated with a B.A. (Honors) degree in Economics from St. Stephen's College, Delhi and holds a B.S. degree in Economics and a Master's degree in Public Affairs from the California State University at Hayward (C.S.C.H.), California, U.S.A.

Dr. Brian W Tempest

Dr. Brian Tempest advises Companies, Banks, Investment Funds, Private Equity & High Net Worth Individuals on their Strategy in Asia based on his wide experience in China, Japan, South East Asia and India where he has lived for the last decade.

Brian started working for Ranbaxy Laboratories in 1995 and he held the positions of Regional Director, President, Managing Director and Chief Executive Officer until 2005 when Ranbaxy became the 9th largest Global Generic Pharmaceutical Company. He then became Chief Mentor, Vice Chairman and Non Executive Director until 2008 when he retired. He is one of the few Westerners to have led a Sensex Nifty 50 Indian blue chip MNC and as a result has a valuable insight into India. Brian has also worked for Glaxo as Regional Director-Far East and Regional Director-Middle East & Africa from 1985 to 1992.

He has worked in the Pharmaceutical Industry for the last 42 years and has managed Healthcare Businesses in North America, South America, Europe, Africa, Middle East, Australasia, China, Japan and India and has led many sessions at Investor Meetings held around the world from Tokyo to Las Vegas.

Brian is Independent Chairman of Religare Capital Markets, a Non Executive Director of SRL Diagnostics, Fortis Healthcare and Glenmark Pharmaceuticals Ltd. Brian speaks at global conferences on the structural changes in the Global Pharmaceutical Marketplace and most of his presentations in the last decade are available on www.briantempest.com.

Brian received a PhD in Chemistry from Lancaster University in 1971 and in 2009 he became Chairman of the Advisory Board for the Lancaster University Management School. He is a Fellow of the Royal Society of Chemistry and a Fellow of the Royal Society of Medicine. He is now Chairman and Senior Partner at Hale & Tempest Co Ltd in the UK.

Dr. P. S. Joshi

Dr. Preetinder Singh Joshi, an eminent Cardiologist, holds an MBBS degree in Medicine from Medical College, Amritsar (Punjab University, Chandigarh 1970) and MD degree in Cardiology & General Medicine from Maulana Azad Medical College (Delhi University 1974). (He stood first in the University and was declared best graduate of Medical College, Amritsar). He became a member of Royal College of Physicians, UK (MRCP) in 1978.

He is a Fellow of American College of Cardiology (FACC), Fellow Royal College of Physicians Edinburgh (FRCP) and Fellow Cardiological Society of India. He has over 40 years of experience in medical profession in India and abroad. He has held many positions of responsibility including Directorship and Head, Department of Medicine & Cardiology Divisions in Escorts Medical Centre (1981-84), Birla Centre for Medical Research, New Delhi (1984-85) & Maharaj Sawan Singh Charitable Hospital, Beas (1985-till date).

Joji Sekhon Gill

Joji Sekhon Gill is a HR veteran, with over 24 years of experience. Her stints in organisations spread across North America, India, Europe and Asia, have given her extensive exposure to best practices in Global Human Resources. She has recently joined DuPont as Strategic Human Resources Director.

Prior to this worked with Microsoft India for six years, as Human Resources Director-a role that made her responsible for managing doubling of the company's headcount from 3,000 to 6,000 people. Earlier, Joji has worked with Symantec, Veritas, and KLA-Tencor, USA.

Joji has a Masters degree in Personnel Management and Industrial Relations from Panjab University, Panjab, India.

Ms. Lynette Joy Hepburn Brown

Ms. Lyn Hepburn-Brown is an executive leader with over 30 years experience in healthcare, mergers and acquisition, private equity, education, regulatory and nursing services management across Asia Pacific.

She is a former executive manager, chief executive and board member of regulatory authorities, aged care facilities, mental health facilities, public and private hospitals, clinical services, nursing and healthcare agencies in Australia, and is presently an executive and non-executive Director for several organisations across the technology, healthcare, consulting, private equity, and memorial sectors.

She holds a Bachelor of Nursing from the University of South Australia and is a past chair of the Australian Nursing and Midwifery Council as well as a past board member of the Nurses Board of South Australia. She is an Adjunct Associate Professor to the Division of Health Sciences of the University of South Australia.

Pradeep Ratilal Raniga

Pradeep Ratilal Raniga has rich experience of over 29 years in the fields of accounting, taxation, legal structures, asset protection, financial planning, and financing. Currently, he also serves as a Financial Consultant to various companies in Australia, a country to which he migrated in 1985, from South Africa.

Prior to branching out independently, Pradeep was with HLB Mann Judd, Melbourne, rising to Partner and Member of the firm's Executive Committee. Before that he was a Partner at Farrar Jeena & Company, South Africa.

Pradeep has a Bachelors degree in Commerce from the University of Durban Westville, South Africa, and a Post-Graduate Diploma in Accounting from the University of Natal, South Africa. He has qualified as a Chartered Accountant in South Africa and is also a member of the Australian Institute of Chartered Accountants.

Udai is a Managing Director with Standard Chartered Private Equity (SCPE) and leads the private equity business in India. He joined SCPE in 2008 and has since then been involved with several of the fund's investments including Café Coffee Day, Fortis Healthcare, Endurance, Firepro, GMR Airports, Interglobe, Sutherland and Varun Beverages. Prior to SCPE, Udai worked for 13 years in financial services focused on corporate investing, M&A and corporate finance, both in India and the United States. Udai's roles have included Senior Vice President at Kotak Mahindra Capital where he led energy and transportation investment banking, Director of Corporate Development at Sabre Inc. where he executed corporate investments of over USD I BN, and as a Consultant with Arthur Andersen in the corporate finance and tax practices.

Udai has an MBA from the Wharton School, University of Pennsylvania and is a chartered accountant from the Institute of Chartered Accountants of India.

Malvinder Mohan Singh

Executive Chairman, Fortis Healthcare Limited

Malvinder is a dynamic, young business leader who has made a mark on the global landscape by simultaneously pursuing the twin objectives of business for profit and for public good, in a way that positively impacts lives.

With the intent of providing broad based world class services through transformative business and delivery models, Malvinder is shaping the contours of the healthcare and financial services industries and driving their evolution.

In Healthcare, Malvinder incubated and established Fortis Healthcare Limited, in the late 1990's. Since then, he has been instrumental in transforming it into a leading healthcare delivery company in India and more recently in Asia, as the largest emerging healthcare organisation.

With a vision of making quality healthcare services accessible to all, he continues to assiduously pursue this objective, to make it a reality, using innovative business models.

In the Financial Services and Insurance sectors, Malvinder has business interests through Religare Enterprises. As Chairman of the company till 2010, he evolved Religare's strategy of creating an integrated financial services organization in India and an emerging global asset management platform.

Previously, Malvinder was Chairman, MD and CEO of Ranbaxy Laboratories. He led the expansion of Ranbaxy through a series of strategic partnerships and acquisitions resulting in Ranbaxy becoming a top 10 generic pharmaceutical company, globally. He spearheaded the coming together of Ranbaxy and Daiichi Sankyo, to create the world's fifteenth largest pharmaceutical company – a move seen as a game-changer by industry experts.

Malvinder strongly believes in the ability of people to do extraordinary things, in challenging environments. In a precedence setting move, he entrusted the management of Religare to a professional management team by stepping down as Chairman of the company in 2010. He continues to oversee his family's majority interest in Religare, as shareholder.

Malvinder has always supported strategic business decisions in the best interest of the companies he has led and continues to lead. The sale of his personal stake in Ranbaxy to Daiichi Sankyo, to secure longevity and a place for Ranbaxy as a top ranking Global Pharmaceutical Company and his decision to exit investments in Parkway Healthcare, emphatically demonstrated his ability to steer his companies, always keeping the best interests of its stakeholders, in mind.

Malvinder has a strong personal belief in the social responsibility of individuals and corporates. With a focus on affordability and accessibility to life saving medicines in emerging and under developed countries; he channelled resources towards innovation, to reduce the cost of ARV medication and for the development of a new low cost synthetic anti-malarial drug. He keenly supports initiatives to provide curative and preventive healthcare to the under privileged in India's villages and urban slums through various foundations and trusts.

Malvinder is a member of the Board of Visitors at the Fuqua School of Business (Duke University, USA) and the Board of the Indian Council for Research on International Economic Relations (ICRIER). He was a member of the first batch of the Young Global Leaders initiative of the World Economic Forum. A graduate in Economics, he earned his MBA from the Fuqua School of Business, Duke University, USA.

Shivinder Mohan Singh

Executive Vice Chairman, Fortis Healthcare Limited

Shivinder Mohan Singh is an entrepreneur who aspires to change the way Healthcare is delivered in the world. He is the Executive Vice Chairman of Fortis Healthcare Limited, a leading, integrated healthcare delivery provider in the Pan Asia-Pacific region. Fortis' healthcare verticals span primary healthcare, speciality day care, diagnostics and hospitals, with an asset base in 10 countries, many of which represent the fastest-growing healthcare delivery markets in the world. Fortis is driven by the vision of becoming a global leader in the integrated healthcare delivery space and the larger purpose of saving and enriching lives through clinical excellence.

Shivinder is also one of the principal promoters of Religare Enterprises Limited, Super Religare Laboratories Limited and Religare Technologies Limited. He was one of the key promoters of global pharma major Ranbaxy Laboratories and a director on its board; playing a strategic role in its sale and in taking the company to the next level, while creating significant long-term value for all stakeholders.

Shivinder has done his MBA with specialisation in health sector management from the Duke University Business School, USA. His significant contribution to Indian Healthcare is widely acknowledged. His strategy for Fortis, and its execution, has been recognised by the Harvard Business School as a case study. For over a decade, Shivinder has led from the front in shaping the private healthcare space in India. He is an alumnus of Doon School and an Honours Graduate in Mathematics from St. Stephens College, Delhi. He has lead various healthcare bodies and state level initiatives for the industry. He is also the Chairman of the Membership Committee of FICCI (Federation of Indian Chambers of Commerce and Industry).

While healthcare is a passion for Shivinder, his dream is to contribute in building a vibrant India. He is involved in a number of initiatives focused on social change - a better future for the girl child, HIV education, quality healthcare in Rural India and more. Shivinder is on the board of visitors of Fuqua School of Business, Duke University, USA and the board of trustees of Aspen India. He is also on the national board of advisors for AIESEC, a global, non-political and independent, not-for-profit organization run by students and graduates from institutions of higher education.

Shivinder lives with his wife Aditi and their four sons, in New Delhi. He likes sports such as football and tennis and enjoys watching films! .

Daljit Singh

President, Fortis Healthcare Limited

Daljit Singh is the President, Fortis Healthcare Limited. He has led the Company’s strategy and organizational development functions and has held the office of CEO. He has over 39 yrs of rich management experience.

Mr Singh has been a pivotal member of the top team of Fortis that formulated and implemented Fortis’ growth strategy to position it as India’s leading Healthcare delivery organization in a short span of 10 yrs.

Prior to joining Fortis, Mr Singh was on the Board of Directors of ICI India, a subsidiary of the British Multinational, as the Executive Director in charge of Human Resources, Manufacturing, External Relations and Communications. Amongst key responsibilities held, he was the Chief Executive for Pharmaceuticals, Specialties and Catalyst businesses. He was member of the ICI Global Manufacturing Group, SSHE Excellence Group and the Global HR Forum. His key experience and achievements have been in the areas of developing progressive HR strategies and ensuring their implementation, organizational restructuring, building a high performance culture and leading teams to deliver business value. He has successfully planned and executed significant change programs.

Mr Singh is an acknowledged expert and thought leader in the domain of Healthcare Delivery. He is on the Steering Boards constituted by the World Economic Forum to guide two major Global projects: “Scenarios for Sustainable Health Systems” and “The Healthy Living Charter”. He is also on the Forum’s Advisory Board on “The Economic Burden of Non Communicable Diseases in India”.

A certified Life and Executive Coach, he works with Senior Management to enhance personal performance and fulfillment. He also leads and facilitates workshops on Strategy, Business Planning & Leadership.

A graduate from the Indian Institute of Technology, Delhi, and Mr. Singh was a Commonwealth Scholar to the Senior Management Programme at the Manchester Business School in 1995. With an outstanding track record in the field of athletics, his current interests include athletics, high altitude trekking, adventure sports, music and reading.

Balinder Singh Dhillon

President, Fortis Healthcare Limited

Balinder Singh Dhillon is a President of Fortis Healthcare Limited. He has been on corporate boards, including those of Ranbaxy Laboratories Ltd, an India listed multi-billion dollar multinational pharmaceutical company, and Parkway Holdings Ltd, a Singapore listed healthcare services company. He has also worked as counsel in practice and with corporate houses such as Hindustan Unilever Limited and INTRIA Items Inc.,(a wholly owned subsidiary of CIBC Bank, Canada). He has more than two decades of experience in corporate law, governance, risk management, and strategic planning and implementation.

A graduate of the Panjab University, Balinder is also a member of the Institute of Company Secretaries of India and the Bar Council of India. He holds a Master of Laws degree from McGill University, Canada. As a member of the Law Society of Upper Canada, he completed his accreditation under a Certificate of Qualification equivalent to a Graduate of Law through the Law Faculty, University of Toronto, Canada

Gagandeep Singh Bedi

Group Chief Financial Officer, Fortis Healthcare Limited, India

Mr. Gagandeep Singh Bedi holds a Bachelor’s degree in Commerce from Delhi University and is a Chartered Accountant from the Institute of Chartered Accountants of India. He has over 18 years of wide experience in the areas of Finance, Total Quality Management, leading a business and a global transformation program. Mr. Bedi joined Fortis Healthcare in 2011 from Philips Healthcare, Netherlands. At Fortis, he set up the Supply Chain and Shared Services function and has delivered exceptional results.

Aditya Vij

Chief Executive Officer, Fortis Healthcare Limited, India

Aditya is a Chartered Accountant from Institute of Chartered Accountants of India and an MBA from International Institute for Management Development (IMD), Lausanne, Switzerland. He has rich management experience spanning three decades in the corporate world with a proven track record of developing and turning around businesses in various leadership positions. Currently, he is the CEO of Fortis Healthcare Ltd., prior to which he was with Punj Lloyd where he held the position of Group President - Defence, a role in which he was responsible for setting up the Defence and Nuclear Power verticals for the Group.

Prior to joining Punj Lloyd, Aditya had a distinguished innings of 18 years with General Motors, across five countries in Europe and Asia. Some of the key positions he held with GM include General Director - Opel Southeast Europe, Hungary, Chairman & Managing Director - GM India and Regional Executive Director - Nordic, Benelux & Switzerland. Among his significant achievements at GM were the turnaround of the India business into a profitable entity, the successful launch of the Chevrolet brand in India, the expansion of production capacity at the car manufacturing plants several-fold, the establishment of an engineering & R&D Centre for Global competitiveness and the setting up of a shared services centre for GM Units worldwide.

K Srivatsan

Chief Financial Officer, Fortis Healthcare International

Srivatsan graduated in Commerce with professional qualifications in Finance, from the Institute of Cost and Works Accountants of India, and Legal, from the Institute of Company Secretaries of India. His overall experience of over 20 years spans pharmaceuticals, healthcare and shipping. Srivatsan has been with Fortis Healthcare since 2011. Prior to joining Fortis Healthcare, he has been with Cipla Limited, Sanofi Aventis Limited, Panacea Biotec Limited, Wockhards Hospitals Limited and Mercator Lines (Singapore) Limited.

Srivatsan's dynamic professional career reflects pioneering experience & year-on-year success in achieving business growth objectives. He has cross functional exposure to Finance & Accounting, Technical, Commercial and Medico-Marketing operations. He is a sound business thinker who focuses on operations and pays attention to details while retaining the ability to look at the big picture: business beyond numbers. Srivatsan is a team player and has the ability to multi task and generate ideas and solutions.

Tan Poh Lan

Chief Executive Officer, Fortis Healthcare, Singapore

Tan Poh Lan is the Chief Executive Officer of Fortis Healthcare, Singapore. In this role, she is responsible for the healthcare business in Singapore, currently comprising Fortis Colorectal Hospital and RadLink-Asia Pte Ltd. She will be actively involved in growing the business in the country to increase the company's profile.

Poh Lan has more than 25 years of experience in the government and private healthcare settings in both Singapore and Vietnam with skills in operations, personnel management, performance/quality improvement and business development. A strong believer of teamwork, she works in collaboration with others toward mutual success of the team's objectives. She has a management style based on strong interpersonal and human relations skills and has the ability to build a motivated team with a strong customer focus.

Prior to joining Fortis, Poh Lan was the Chief Executive Officer of Vinmec International Hospital, Hanoi - a 500 bed hospital that was recently commissioned and started operations in January 2012. Before this, she has assumed senior leadership roles in Parkway Healthcare as the Chief Executive Officer of Gleneagles Hospital, Chief Executive Officer of East Shore Hospital and Assistant General Manager of Mount Elizabeth Hospital.

Poh Lan graduated from University of Queensland, Australia with a Bachelor of Occupational Therapy (Honours) under the Colombo Plan Scholarship. She has a Master of Business Administration from the National University of Singapore.

Dr. Simmardeep Singh Gill

Chief Operating Officer, Fortis Clinique Darné, Mauritius

Dr. Simmar Gill is a medical graduate and holds a Post-Graduation in Healthcare and Hospital Management. He has over twelve years of experience in the healthcare industry, ten of which have been at Fortis Healthcare. Before taking over as Chief of Fortis Clinique Darné, he was heading Fortis Hospitals, Bangalore, and was instrumental in turning it around from a sick unit into a renowned Kidney Institute of the region. Prior to his stint at Bangalore, Dr Gill successfully led Fortis Mohali to achieve a JCI and NABH accreditation, making it the first hospital in India to do so. In the course of his career, he has attended various prestigious programs linked to healthcare management and accreditations in the US and renowned management institutes in India. Simmar is passionate about running Fortis Hospitals with an aim to deliver top quality healthcare and world class services that Fortis is synonymous with.